Skip to content

Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy

Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy - a Controlled, Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01311440
Enrollment
75
Registered
2011-03-09
Start date
2011-03-31
Completion date
2017-07-31
Last updated
2017-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Focal Epilepsy, Generalized Epilepsy

Keywords

RCT, modified Atkins diet, epilepsy, adults, ketogenic diet

Brief summary

In Oslo University Hospital, department of complex epilepsy, offer ketogenic diet to treat children with medically intractable epilepsy. From 2009 we added modified Atkins diet as a treatment option for children up to 18 years. We now initiate an open, prospective, randomized and controlled study with the aim to test the efficacy of treatment with modified Atkins diet in adults with focal and generalized epilepsy diagnoses, in order to evaluate whether this treatment should be offered to patients on a permanent basis.

Detailed description

Poorly controlled epilepsy in adults affects health and quality of life in many ways. Within this heterogenous population there are individuals who are motivated for a very strict diet in order to reduce seizures. Among adults with epilepsy 75 - 80 % are diagnosed with focal epilepsy, while 20 - 25 % have generalized onset of seizures. We plan to include 92 patients with focal epilepsy diagnosis. Those are randomized into diet and control groups. During the inclusion period we also treat patients with generalized epilepsy that qualify for participation, but these are not to be randomized, rather they will follow the diet group course. We assume 18 - 23 patients with generalized epilepsy will be included in the project.

Interventions

OTHERModified Atkins diet treatment

Eat a diet containing 16 grams of carbohydrates per day, maximize on fat. Assure sufficient intake of micronutrients.

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Focal or generalized epilepsy diagnosis * More than 3 recordable seizures per month * BMI \> 18,5 * Not responded to at least three 3 AEDs * 16 years or older * Motivated to complete the diet after thorough information * Capable of recording seizures * Capable of preparing the diet

Exclusion criteria

* Hypercholesterolemia, cardiovascular disease or kidney disease * Been on modified Atkins diet for more than one week during the last year * Status epilepticus last six months * epilepsy surgery or VNS implant last year * 4 weeks continuous seizure freedom last 2 months * PNES seizures * other disease where dietary treatment is contraindicated * usage of drugs or supplements that may interfere with diet or AED * being pregnant or planning pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in seizure frequency12 weeksAll participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.

Secondary

MeasureTime frame
Change in standard 3-hrs EEG12 weeks
Change in life quality measured by validated questionnaire12 weeks
Change in body weight12 weeks
Change in executive functions measured with validated questionnaire12 weeks
Change in seizure strength and severity measured by validated questionnaire12 weeks
Change in various blood and serum measures12 weeks

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026